Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19

As the global community strives to discover effective therapies for COVID-19, immunomodulatory strategies have emerged as a leading contender to combat the cytokine storm and improve clinical outcomes in patients with severe disease. Systemic corticosteroids and selective cytokine inhibitory agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Stephen Y., Chang, C-Hong, Meizlish, Matthew L., Bahel, Parveen, Rinder, Henry M., Lee, Alfred I., Chun, Hyung J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781335/
https://www.ncbi.nlm.nih.gov/pubmed/33398292
http://dx.doi.org/10.1101/2020.12.23.20248547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781335/
https://www.ncbi.nlm.nih.gov/pubmed/33398292
http://dx.doi.org/10.1101/2020.12.23.20248547

Ejemplares similares